PedAM
Pediatric Disease Annotations & Medicines
| Disease | interstitial lung disease |
| Symptom | C0020542|pulmonary hypertension |
| Sentences | 19 |
| PubMedID- 23543646 | Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water. |
| PubMedID- 22415303 | Little is known regarding the cellular and molecular mechanisms that lead to pulmonary hypertension in patients with interstitial lung disease, and effective treatment options are lacking. |
| PubMedID- 21613438 | Purpose: to study the reliability of pulmonary vascular measurements based on computed tomography (ct) in the prediction of pulmonary hypertension (ph) in patients with advanced interstitial lung disease (ild) compared with those without ild. |
| PubMedID- 26283756 | Objectives: this study was conducted to evaluate the value of sonographic b-lines (previously called "comet tail artifacts") in assessment of pulmonary hypertension in patients with interstitial lung diseases. |
| PubMedID- 21846759 | Ct detection of pulmonary hypertension in interstitial lung disease: the glass is half full. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 25378843 | the prevalence of isolated pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease in systemic sclerosis were similar and ranged between 18 and 22% in various studies. |
| PubMedID- 22425136 | pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 26473476 | However, our study could not adjust for pulmonary hypertension, a complication of interstitial lung disease, including idiopathic lung fibrosis. |
| PubMedID- 21536179 | pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 23034317 | Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease. |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 21454061 | Conclusion: severe kco reduction is frequently related to pulmonary hypertension, especially when associated with emphysema and/or interstitial lung disease. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
Page: 1